Publications
56
Citations
1,576
Est. group size
—
Recurring co-author estimate
Active years
25
Publishing since 2002
Joelle M. Fenger studies cancer in dogs, using them as models to understand and treat tumors such as osteosarcoma (a bone cancer), lymphoma, and urothelial carcinoma. Her work spans drug testing (including chemotherapy and targeted therapies), biomarker discovery (like exosomal gene signatures and blood proteins), and genomic analysis of canine tumors, often with implications for comparative and precision medicine relevant to both veterinary and human cancer care. This research is conducted within the field of veterinary oncology and translational cancer biology.
Publication output rose to a peak around 2018-2021 but has slowed notably in the last few years, with output remaining low through 2022-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Dogs as a Model for Cancer: An Update
Annual Review of Animal Biosciences · 2026
- A prospective observational study of 345 canines with ruptured splenic tumors suggests benign lesions are more common than previously reported
Journal of the American Veterinary Medical Association · 2025
- Tolerability Assessment of Orally Administered Paclitaxel With Encequidar in Dogs With Spontaneous Malignancy
Veterinary and Comparative Oncology · 2025
- Precision Medicine
CABI eBooks · 2023
- Pharmacokinetic Exposures Associated With Oral Administration of Sorafenib in Dogs With Spontaneous Tumors
Frontiers in Veterinary Science · 2022
- The selective inhibitor of nuclear export (<scp>SINE</scp>) verdinexor exhibits biologic activity against canine osteosarcoma cell lines
Veterinary and Comparative Oncology · 2021
- Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning
Laboratory Investigation · 2021
- Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines
BMC Veterinary Research · 2021
- Serum IL‐6 and MCP‐1 concentrations in dogs with lymphoma before and after doxorubicin treatment as a potential marker of cellular senescence
Veterinary Medicine and Science · 2021
- Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning
bioRxiv (Cold Spring Harbor Laboratory) · 2021
- Abstract 671: Development of an exosomal biomarker signature to detect minimal residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning
Cancer Research · 2021
- Author response for "Serum IL‐6 and MCP‐1 concentrations in dogs with lymphoma before and after doxorubicin treatment as a potential marker of cellular senescence"
2021
- Author response for "Serum IL‐6 and MCP‐1 concentrations in dogs with lymphoma before and after doxorubicin treatment as a potential marker of cellular senescence"
2021
- Evaluation of microwave ablation for local treatment of dogs with distal radial osteosarcoma: A pilot study
Veterinary Surgery · 2020
- S100A4 mRNA-protein relationship uncovered by measurement noise reduction
Journal of Molecular Medicine · 2020
- Cancer Research×4
- Figshare×4
- Veterinary and Comparative Oncology×3
- Frontiers in Oncology×2
- Journal of Veterinary Internal Medicine×2
- Nelly O. Elshafie
Medicine · Purdue University West Lafayette
- Nikolaos Dervisis
Medicine · Purdue University West Lafayette
- William C. Kisseberth
Medicine · The Ohio State University
- Michael O. Childress
Medicine · Purdue University West Lafayette
- Maxey L. Wellman
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile